179 related articles for article (PubMed ID: 25944189)
21. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program.
Schenker EL; Hultin LE; Bauer KD; Ferbas J; Margolick JB; Giorgi JV
Cytometry; 1993; 14(3):307-17. PubMed ID: 8472607
[TBL] [Abstract][Full Text] [Related]
22. Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies.
Boldt A; Borte S; Fricke S; Kentouche K; Emmrich F; Borte M; Kahlenberg F; Sack U
Cytometry B Clin Cytom; 2014 May; 86(3):191-206. PubMed ID: 24488780
[TBL] [Abstract][Full Text] [Related]
23. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
24. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
25. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
Hudnall SD; Patel J; Schwab H; Martinez J
Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
[TBL] [Abstract][Full Text] [Related]
26. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
27. Novel use of the BD FACS SPA to automate custom monoclonal antibody panel preparations for immunophenotyping.
Kelliher AS; Parent DW; Anderson DC; Dorn ME; Hahn JL; Eapen S; Preffer FI
Cytometry B Clin Cytom; 2005 Jul; 66(1):40-5. PubMed ID: 15918157
[TBL] [Abstract][Full Text] [Related]
28. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets.
Mittag A; Lenz D; Gerstner AO; Sack U; Steinbrecher M; Koksch M; Raffael A; Bocsi J; Tárnok A
Cytometry A; 2005 Jun; 65(2):103-15. PubMed ID: 15830380
[TBL] [Abstract][Full Text] [Related]
29. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
Porwit A
Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
[TBL] [Abstract][Full Text] [Related]
31. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of the ClearLLab 10C B cell tube.
Espasa A; Torrents S; Morales-Indiano C; Rico LG; Bardina J; Ancochea A; Bistué-Rovira À; Linio R; Raya M; Vergara S; Juncà J; Grifols JR; Petriz J; Soria MG; Sorigue M
Cytometry B Clin Cytom; 2021 Jul; 100(4):519-530. PubMed ID: 32961011
[TBL] [Abstract][Full Text] [Related]
33. Abnormalities by Multicolor Flow Cytometry for Detection of Minimal Residual Disease in Recipients of Allo-HSCT Originating from Donors: A Cohort Study.
Wang H; Wang A; Chen M; Gong M; Wu X; Zhen J; Lu Y
Turk J Haematol; 2023 Feb; 40(1):18-27. PubMed ID: 36718627
[TBL] [Abstract][Full Text] [Related]
34. Composition of lymphocyte subpopulations in normal canine lymph nodes.
Rütgen BC; König R; Hammer SE; Groiss S; Saalmüller A; Schwendenwein I
Vet Clin Pathol; 2015 Mar; 44(1):58-69. PubMed ID: 25512102
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
36. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of five commercial reagents for preparing normal and leukaemic lymphocytes for immunophenotypic analysis by flow cytometry.
Macey MG; McCarthy DA; Milne T; Cavenagh JD; Newland AC
Cytometry; 1999 Aug; 38(4):153-60. PubMed ID: 10440853
[TBL] [Abstract][Full Text] [Related]
38. Flow-cytometric immunophenotyping of normal and malignant lymphocytes.
Szczepański T; van der Velden VH; van Dongen JJ
Clin Chem Lab Med; 2006; 44(7):775-96. PubMed ID: 16776621
[TBL] [Abstract][Full Text] [Related]
39. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples.
van der Velden VHJ; Flores-Montero J; Perez-Andres M; Martin-Ayuso M; Crespo O; Blanco E; Kalina T; Philippé J; Bonroy C; de Bie M; Te Marvelde J; Teodosio C; Corral Mateos A; Kanderová V; van der Burg M; Van Hoof D; van Dongen JJM; Orfao A
J Immunol Methods; 2019 Dec; 475():112287. PubMed ID: 28341440
[TBL] [Abstract][Full Text] [Related]
40. Gating strategy for immunophenotyping of leukemia and lymphoma.
Sun T; Sangaline R; Ryder J; Gibbens K; Rollo C; Stewart S; Rajagopalan C
Am J Clin Pathol; 1997 Aug; 108(2):152-7. PubMed ID: 9260755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
